The GEPIA study reveals that, when compared with normal tissues, the expression of DNMT1 is elevated in CHOL, DLBC, head and neck squamous cell carcinoma (HNSC), pancreatic adenocarcinoma (PAAD), sarcoma (SARC), and thymoma (THYM). Here, DNMT1 is linked to sarcoma.